This dataset is intended for researchers, students, and policy makers for reference and mapping purposes, and may be used for basic applications such as viewing, querying, and map output production, or to provide a basemap to support graphical overlays and analysis with other spatial data.

Abstract copyright UK Data Service and data collection copyright owner.

This project aimed to develop a model of health care use, using the most appropriate econometric techniques. The first step was to model health care demand in the Solihull Primary Care Trust (PCT) (now Solihull NHS Care Trust) area as defined by GP visits, inpatient visits and outpatient visits. The next step was to make forecasts of demand based on a range of scenarios. The aim was to provide the Trust with a model that they could use to run their own bespoke demographic and lifestyle scenarios to calculate future changes demand for health services.
Main Topics:

The data files comprise anonymised accident and emergency, general practitioner, inpatient and outpatient data from the Solihull PCT/NHS Care Trust from 2005-2011. The files are CSV outputs from a database. Users should note that many of the files are in .txt format and rather than commas, the separator characters may be '|' or '^'. The large size of the data files may mean that they are not suitable for analysis in Excel or standard text editors.

Solihull. name, office head of government, Mayor, image, Area, date founded, Elevation, Country, administrative division, continent, latitude, waterbody, longitude, Website, population, Demonym

Number of Antibiotic Guardians per 100,000 population across NHS Integrated Care Board (ICB) sub-levels

Rationale Antibiotic Guardian is a UKHSA-led behaviour change campaign to encourage improved behaviours and engagement on the prudent use and prescription of antibiotics with members of the public and healthcare professionals. The indicator shows the rates of Antibiotic Guardians per 100,000 population per year as a measure of engagement within the area on antibiotic resistance. For this indicator, a higher rate is indicative of increased engagement.

Definition of numerator Antibiotic Guardian pledgees in England.

Definition of denominator ONS mid-year estimates based on ICB sub-level boundaries

This statistic illustrates the output of vehicles by Land Rover in Solihull, United Kingdom (UK) in 2014, in units. Land Rover is specialized in four-wheel drive vehicles and part of Jaguar Land Rover. It was founded in 1948 as Rover Company. Today Jaguar Land Rover is a subsidiary of the Ford Motor Company. In 2014, the most produced car by the Land Rover company in Solihull (UK) was the Range Rover, with over 140,000 units produced. The second and third most popular Land Rover models were the Discovery and the Defender, with an output of 50,631 Land Rover Discovery vehicles and 7,727 Land Rover Defender vehicles.

Laboratory confirmed cases of MRSA bacteraemia. Community-onset cases are all those that are not hospital-onset cases. Hospital-onset is determined by patient location, date of admission, date of specimen, and patient category. Hospital onset is only indicative for cases where NHS patient specimens are taken on the third day of admission onwards (e.g., day three when day one equals the day of admission) at an acute trust (including cases with unspecified specimen location) for inpatients, day patients, emergency assessment, or unspecified patient category. Records with a missing admission date (where the specimen location is acute trust or missing and the patient category is inpatient, day patient, emergency assessment, or unspecified) are also included. Other cases may have hospital onset, but not in acute trusts.

Data is available by Sub ICB (Integrated Care Board) location.

Rationale A long-running voluntary surveillance scheme of laboratory-reported cases of Staphylococcus aureus bacteraemia showed increasing incidence of meticillin-resistant S. aureus (MRSA) infections in England, Wales, and Northern Ireland in the 1990s. This generated both media and public interest. In response, the Department of Health (DH) in England introduced a mandatory surveillance scheme for S. aureus bacteraemias in April 2001, which included data on the number of cases that were due to MRSA. In October 2005, the mandatory surveillance scheme for MRSA bacteraemias was enhanced to collect patient-level data. Additionally, all NHS organisations reporting cases of MRSA bacteraemia from 1 April 2013 were required to complete a Post Infection Review (PIR). This process was commenced to support the delivery of zero tolerance on MRSA bacteraemia, as set out by NHS England in the Planning Guidance Everyone counts: Planning for Patients 2013/14. A PIR is undertaken after all MRSA bacteraemias with the purpose of identifying how a case occurred, to identify actions by local healthcare teams which will prevent a reoccurrence, and to identify the organisation best placed to ensure improvements are made (this is known as “assigning” a case to an organisation). From 1 April 2018, the PIR process changed from being applied by all trusts to trusts identified as having high rates of MRSA. For more information, please see MRSA Guidance: Post Infection Review. A low value is indicative of a low rate of MRSA.

Source of numerator UK Health Security Agency (UKHSA), Healthcare Associated Infection Data Capture System (HCAI DCS) Mandatory Surveillance

Source of denominator Office for National Statistics (ONS), Mid-year population estimates

Caveats These data do not provide a basis for decisions on the clinical effectiveness of infection control interventions in individual Trusts: further investigations considering potential confounders would need to be undertaken before this could be done.

Nor do these data provide a basis for comparisons between acute Trust or SICBLs. Rate information, using rate calculations as currently defined, is not appropriate for comparison. The counts of infections have not been adjusted to give a standardised rate considering factors such as organisational demographics or case mix. Rate information is of use for comparison of an individual organisation over time.

‘All reported cases’ refers to all MRSA-positive blood cultures reported by the Trust whose laboratory processes the specimen. It is important to note that this does not necessarily imply that the infection was acquired there.

Confidence intervals for rates are not currently calculated because appropriate methods for comprehensive coverage are being assessed.

Cases that the UKHSA’s HCAI Data Capture System attributes to a commissioning hub (such as the national commissioning hub, 13Q, or one of the regional Health & Justice commissioning hubs) are not featured in sub ICB Location dashboards but they do still contribute to the highest spatial level—the England national total. This means the England case total & rates may be slightly higher than the sum of all sub ICB Location cases & rates.

IMPORTANT NOTE: SICBL calculations for the period between January 2021 and January 2022 have been based on SICBL boundaries. As such some SICBLs may experience higher or lower rates than expected due to this change. Those SICBLs affected are; Bassetlaw, Glossop, East Leicestershire and Rutland, Lincolnshire, Cambridgeshire and Peterborough, Birmingham and Solihull, Black Country and West Birmingham and Oundle.

A lookup file between 2011 Lower Layer Super Output Areas (LSOA), to clinical commissioning groups (CCG) and local authority districts (LAD) in England, as at 1 April 2018. (File size - 8MB) This file includes the newly formed CCGs - NHS Birmingham and Solihull CCG (E38000220), NHS Berkshire West CCG (E38000221), NHS Bristol, North Somerset and South Gloucestershire CCG (E380002220), NHS Buckinghamshire CCG (E38000223), NHS East Berkshire CCG (E38000224) and NHS Leeds CCG (E38000225) It also includes changes to the codes for NHS Fylde and Wyre CCG (E38000226), NHS Greater Preston CCG (E38000227) and NHS Morecambe Bay CCG (E38000228) following a boundary change. It also includes the local authority name change of Shepway to Folkestone and Hythe (E07000112) Field Names - LSOA11CD, LSOA11NM, CCG18CD, CCG18CDH, CCG18NM, LAD18CD, LAD18NMField Types - Text, Text, Text, Text, Text, Text, TextField Lengths - 9, 33, 9, 3, 57, 9, 28

A lookup file between clinical commissioning groups (CCGs) and sustainability and transformation partnerships (STP) in England as at 1 April 2018. (File size - 64KB)

This file includes the newly formed CCGs - NHS Birmingham and Solihull CCG (E38000220), NHS Berkshire West CCG (E38000221), NHS Bristol, North Somerset and South Gloucestershire CCG (E380002220), NHS Buckinghamshire CCG (E38000223), NHS East Berkshire CCG (E38000224) and NHS Leeds CCG (E38000225). It also includes changes to the codes for NHS Fylde and Wyre CCG (E38000226), NHS Greater Preston CCG (E38000227) and NHS Morecambe Bay CCG (E38000228) following a boundary change.

The file has been updated to include the merger of 3 STPs - (E54000045, E54000046, E54000047) to form E54000049 - Cumbria and North East STP

Field Names - CCG18CD, CCG18CDH, CCG18NM, STP18CD, STP18NM

Field Types - Text, Text, Text, Text, Text

Field Lengths - 9, 3, 57, 9, 49

This file is a lookup between Clinical Commissioning Groups, NHS England (Region, Local office) and NHS England (Region), as at 1 April 2018 in England. (File size - 88KB).

Un file di ricerca tra 2011 Lower Layer Super Output Areas (LSOA), ai gruppi di messa in servizio clinica (CCG) e distretti delle autorità locali (LAD) in Inghilterra, al 1 ° aprile 2018. (Dimensione file - 8MB)

Nomi di campo - LSOA11CD, LSOA11NM, CCG18CD, CCG18CDH, CCG18NM, LAD18CD, LAD18NM

/div>